賴納克氏鹽一水物號：13573-16-5   
英文名稱：Reinecke salt monohydrate；Ammonium reineckate monohydrate；Ammonium tetrathiocyanatodiamminechromate monohydrate   
其他名稱：雷氏鹽一水物；利英納克鹽一水物；四硫氰基二氨絡(luò)鉻酸銨一水物；利英鈉克鹽一水物；二氨基四硫代氰酸鉻銨一水物；二氨合四氰硫基鉻酸銨(III)一水物   
號：13573-16-5   
C4H10CrN7S4·H2O=354.43   
級別：AR   
水溶解試驗(yàn)：合格   
對化*靈敏度試驗(yàn)：合格   
性狀(以下信息僅供參考)：深紅色結(jié)晶或紅色結(jié)晶性粉末。溶于熱水和乙醇,微溶于冷水。在水溶液中分解游離氫青酸而成藍(lán)色。室溫時分解約在二周內(nèi)發(fā)生,溫度高于65℃時速度加快。在沸乙醇中有相似分解發(fā)生。熔點(diǎn) 268～272℃(分解)。   
用途：本品僅供科研，不得用于其它用途。(以下用途僅供參考)比色測定*及其他有機(jī)堿。伯胺、仲胺、*、羥基*和某些氨基酸的沉淀劑。汞的顯色劑和沉淀劑   
保存：RT 賴納克氏鹽一水物號：13573-16-5儲存條件：
避光、干燥陰涼處封閉貯存,嚴(yán)禁與有毒、有害物品混放、混運(yùn)。本品為非危險(xiǎn) 產(chǎn)品可按一般化學(xué)品運(yùn)輸,輕搬動輕放,防止日曬、雨淋！受熱、受潮、受光后易喪失活力,保存期短,因此貯存和運(yùn)輸條件比較苛刻。
運(yùn)輸：汽車運(yùn)輸、EMS郵政快遞，申通快遞等， 款到上海3天內(nèi)發(fā)貨； 
售后：如您對我們的產(chǎn)品服務(wù)及技術(shù)指標(biāo)有特殊要求，請及時通知我方。 
存儲：應(yīng)貯存在干燥清潔避光的環(huán)境中，嚴(yán)禁與有毒物質(zhì)混放，以免污染（保質(zhì)期為兩年）。 
主要優(yōu)級純、分級純和化學(xué)純3種：
（1）優(yōu)級純（GR：Guaranteed reagent），又稱一級品或保證試劑，99.8%，這種試劑純度Z高，雜質(zhì)含量Z低，適合于重要精密的分析工作和科學(xué)研究工作，使用綠色瓶簽。
（2）分析純（AR），又稱二級試劑，純度很高，99.7%，略次于優(yōu)級純，適合于重要分析及一般研究工作，使用紅色瓶簽。
（3）化學(xué)純（CP），又稱三級試劑，≥ 99.5%，純度與分析純相差較大，適用于工礦、學(xué)校一般分析工作。使用藍(lán)色（深藍(lán)色）標(biāo)簽。
（4）實(shí)驗(yàn)試劑（LR：Laboratory reagent），又稱四級試劑。
服務(wù)承諾：
工作時間內(nèi)提供免費(fèi)的技術(shù)咨詢和指導(dǎo) 。我公司的銷售工程師經(jīng)過專業(yè)培訓(xùn)的，將為您提供滿意的產(chǎn)品和真誠的服務(wù)。
 optimal dilutions/concentrations should be determined by the end user. 
保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs.
Subunit : Heterodimer of a C-terminal fragment N(TM) and an N-terminal fragment N(EC) which are probably linked by disulfide bonds (By similarity).Interacts with MAML1, MAML2 and MAML3 which act as transcriptional coactivators for NOTCH2. Interacts with RELA/p65 (By similarity).
Subcellular Location : Cell membrane; Single-pass type I membrane protein. Notch 2 intracellular domain: Nucleus.
Tissue Specificity : Expressed in the brain, heart, kidney, lung, skeletal muscle and liver. Ubiquitously expressed in the embryo.
Post-translational modifications : Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin dependent gamma-secretase to release a notch-derived peptide containing the intracellular domain (NICD) from the membrane (By similarity).
DISEASE : Defects in NOTCH2 are the cause of Alagille syndrome type 2 (ALGS2) [MIM:610205]. Alagille syndrome is an autosomal dominant multisystem disorder defined clinically by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems.
Similarity : Belongs to the NOTCH family.
Contains 6 ANK repeats.
Contains 35 EGF-like domains.
Contains 3 LNR (Lin/Notch) repeats.
英文名稱  Anti-Phospho-IKB beta (Ser23) 
中文名稱  磷酸化KB抑制蛋白β抗體
別    名  IKB beta (Phospho-Ser23); IKB beta (Phospho-S23); p-IKB beta (Ser23); p-IKB beta (S23); phospho-NFKBIB(Ser23); NFKBIB(phospho S23); IkB-beta(Phospho-Ser22); IkB beta; NF-kappa-B inhibitor beta; IKB beta; NF-kappa-BIB; TRIP-9; I-kappa-B-beta; IkappaBbeta; IkB-beta; IkB-B; Thyroid receptor-interacting protein 9; TR-interacting protein 9; NFKBIB; IKBB.
濃    度  1mg/1ml
規(guī) 格  0.1ml/100μg
抗體來源  Rabbit 
克隆類型  polyclonal
交叉反應(yīng)  Human, Mouse, Rat, Pig, Cow, Horse, Rabbit
產(chǎn)品類型  一抗  磷酸化抗體  
研究領(lǐng)域  腫瘤 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 生長因子和激素 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶 
蛋白分子量  predicted molecular weight: 39kDa
性    狀  Lyophilized or Liquid
免 疫 原  KLH conjugated synthesised phosphopeptide derived from human NFKBIB around the phosphorylation site of Ser23
亞    型  IgG
純化方法  affinity purified by Protein A
儲 存 液  0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide